Viewing Study NCT02759835

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:16 PM
Ignite Modification Date: 2026-05-18 @ 8:32 PM
Study NCT ID: NCT02759835
Status: COMPLETED
Last Update Posted: 2024-06-07
First Post: 2016-04-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Adenocarcinoma View
None Lung Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EGFR Tyrosine Kinase Inhibitors View
None T790M Mutation View
None Local Ablative Therapies View
None Oligoprogressive Disease View
None Acquired Resistance View